4:07 PM
 | 
Oct 11, 2018
 |  BC Week In Review  |  Financial News  |  Completed Offerings

Cancer company Rgenix raises $40M series C

Rgenix Inc. (New York, N.Y.) raised $40 million on Oct. 9 in a series C round led by Lepu Medical. New investors Oceanpine Capital and the corporate venture fund of WuXi AppTec Co. Ltd. (Shanghai:603259) also participated, as...

Read the full 170 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$30 USD
More Info >